Hamilton Thorne Ltd.
HTL
Pozycja w akcjach
#16930
Hamilton Thorne Ltd. is a leading enterprise focused on the development,... Hamilton Thorne Ltd. is a leading enterprise focused on the development, manufacturing, and global distribution of specialized instrumentation, laboratory equipment, consumables, software, and a range of services. The company's offerings are primarily directed towards the fields of assisted reproductive technologies (ART), scientific research, and cell biology. Their product line includes sophisticated laser and imaging systems designed for biological studies, custom-built workstations, incubators, and essential equipment for IVF laboratories. They also produce critical medical devices for reproductive medicine, such as ovum pickup needles and catheters, and provide comprehensive in-vitro diagnostic (IVD) systems, from initial research and design to sales, installation, and ongoing servicing. Environmental control solutions like the Cell-Tek Microscope Chamber, which meticulously manages temperature, airflow, and humidity, are also part of their extensive catalog, alongside laminar flow workstations. Furthermore, Hamilton Thorne pioneers software innovations, including AI-powered CASA (Computer-Assisted Sperm Analysis) for image analysis. The company's service array covers thorough laboratory testing, notably endotoxin analysis and specialized sperm assays (like the Sperm Motility Index and Sperm Penetration), as well as the provision of fresh and cryopreserved mouse embryos, coupled with technician training and proficiency testing programs. Marketed under respected brand names such as Hamilton Thorne, Gynemed, Planer, Tek-Event, IVFtech, MICROPTIC, Gynétics, and Embryotech, their products and services reach a diverse global customer base—including fertility clinics, hospitals, pharmaceutical and biotechnology companies, academic institutions, and various commercial research entities—via a direct sales presence in countries like the United States, Germany, France, Australia, Denmark, Belgium, Spain, and the United Kingdom, complemented by an extensive distributor network covering around 100 nations. Hamilton Thorne Ltd. maintains its headquarters in Beverly, Massachusetts.
Cena akcji
$1.59
Ostatnia synchronizacja: 2024-12-02
Kapitalizacja rynkowa
$245.66M
Zmiana (1 dzień)
-0.29%
Zmiana (1 rok)
0.22%
Kraj
US
Handel Hamilton Thorne Ltd. (HTL)
Kategoria
Healthcare
Przychody dla Hamilton Thorne Ltd. (HTL)
Przychody w Sep 2024 TTM: $76.72M
Według najnowszych raportów finansowych Hamilton Thorne Ltd., obecny przychód firmy (TTM) wynosi $76.72M. W roku 2022 firma osiągnęła przychód w wysokości $55.87M wzrost w porównaniu do przychodu z roku 2021, który wynosił $52.35M. Przychód to całkowita kwota dochodu generowana przez firmę ze sprzedaży towarów lub usług. W przeciwieństwie do zysku, nie są odliczane żadne koszty.
Historia przychodów firmy Hamilton Thorne Ltd. od 2008 do 2026
Przychody na koniec każdego roku
| Rok | Przychody | Zmień |
|---|---|---|
| 2026 (TTM) | $76.72M | 14.13% |
| 2023 | $67.23M | 20.32% |
| 2022 | $55.87M | 6.72% |
| 2021 | $52.35M | 31.61% |
| 2020 | $39.78M | 12.50% |
| 2019 | $35.36M | 21.03% |
| 2018 | $29.21M | 32.06% |
| 2017 | $22.12M | 110.38% |
| 2016 | $10.51M | 16.39% |
| 2015 | $9.03M | 3.75% |
| 2014 | $8.71M | 16.45% |
| 2013 | $7.48M | 18.20% |
| 2012 | $6.33M | -11.64% |
| 2011 | $7.16M | 15.46% |
| 2010 | $6.20M | 29.32% |
| 2009 | $4.79M | 13,987.95% |
| 2008 | $34.03K | 0.00% |
Przychody podobnych firm lub konkurentów
| Firma | Przychody | Różnica w przychodach | Kraj |
|---|---|---|---|
| $11.03B | 14,282.21% |
US
|
|
| $34.74B | 45,175.54% |
FR
|
|
| - | - |
JP
|
|
| $20.84B | 27,061.50% |
US
|
|
| - | - |
CH
|
